Professional implications of the expansion of pharmacy-based medical clinics

Journal of the American Pharmacists Association

Volumn 47, Issue 3, 2007, Pages 410-415

  Farley, Joel F ^a   Devine, Joshua W ^b   Hadsall, Ronald S ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b USAF   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Community and ambulatory pharmacy; Pharmacy based medical clinics; Prescriptive authority

Indexed keywords

ARTICLE; MANPOWER; OUTPATIENT DEPARTMENT; PHARMACIST; PHARMACY; PROFESSIONAL STANDARD; UNITED STATES;

AMBULATORY CARE FACILITIES; COMMUNITY PHARMACY SERVICES; PHARMACISTS; PROFESSIONAL ROLE; UNITED STATES;

EID: 34548275529     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2007.06093     Document Type: Note

References (32)

1. Schommer JC, Pedersen CA, Gaither CA, et al. Pharmacists' desired and actual time in work activities: evidence from the 2004 National Pharmacist Workforce Study. J Am Pharm Assoc. 2006;46:340-7.
2. Pracht EE, Moore WJ. Interest groups and state Medicaid drug programs. J Health Polit Policy Law. 2003;28:9-39.
3. Cardinale V. Flying high. Drug Topics. 2005(Mar 21). Accessed at www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=151425&date= &pageID=2, August 17, 2006.
4. Federal Deficit Reduction Act, House Report 109-362, H.R. 4241, S. 1932; 2005.
5. Weitzel K, Goode J. Implementation of a pharmacy-based immunization program in a supermarket chain. J Am Pharm Assoc. 2000;40:252-6.
6. Rosenbluth S, Madhavan S, Borker R, Maine L. Pharmacy immunization partnerships: a rural model. J Am Pharm Assoc. 2001;41:100-7.
7. Ernst ME, Chalstrom CV, Currie JD, Sorofman B. Implementation of a community pharmacy-based influenza vaccination program. J Am Pharm Assoc. 1997;37:570-80.
8. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in project ImPACT: hyperlipidemia. J Am Pharm Assoc. 2000;40:157-65.
9. Kennedy DT, Giles JT, Chang ZZG, et al. Results of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc. 2002;42:51-6.
10. Knowlton CH, Thomas OV, Williamson A, et al. Establishing community pharmacy-based anticoagulation education and monitoring programs. J Am Pharm Assoc. 1999;39:368-74.
11. Berringer R, Shibley MC, Cary CC, et al. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc. 1999;39:791-7.
12. Ernst ME, Doucette WR, Dedhiya SD, et al. Use of point-of-service health status assessments by community pharmacists to identify and resolve drug-related problems in patients with musculoskeletal disorders. Pharmacotherapy. 2001;21:988-97.
13. Kassam R, Farris KB, Burback L, et al. Pharmaceutical care research and education project: pharmacists' interventions. J Am Pharm Assoc. 2001;41:401-10.
14. Shibley MC, Pugh CB. Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners. Ann Pharmacother. 1997;31:713-9.
15. Elliott ME, Meek PD, Kanous NL, et al. Osteoporosis screening by community pharmacists: use of National Osteoporosis Foundation resources. J Am Pharm Assoc. 2002;42:101-10.
16. Simpson SH, Johnson JA, Tsuyuki RT. Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacists. Pharmacotherapy. 2001;21:627-35.
17. Tice B, Phillips CR. Implementation and evaluation of a lipid screening program in a large chain pharmacy. J Am Pharm Assoc. 2002;42:413-9.
18. Doucette WR, Kreling DH, Schommer JC, et al. Evaluation of community pharmacy service mix: evidence from the 2004 National Pharmacist Workforce Study. J Am Pharm Assoc. 2006;46:348-55.
19. Sullivan D. Retail health clinics are rolling your way. Fam Pract Manag. 2006;13:65-72.
20. Institute of Medicine. Coverage matters: insurance and health care. Washington, D.C.: National Academy Press; 2001.
21. Feldman R, Parente ST, Abraham J, et al. Health savings accounts: early estimates of national take-up. Health Aff. 2005;24:1582-91.
22. Harris Poll. Many agree on potential benefits of onsite clinics in major retail stores that can provide basic medical services, yet large numbers are skeptical. Accessed at www.harrisinteractive.com/news/newsletters/wsjhealthnews/ WSJOnline-HI-Health-CarePoll2005vol4-iss21.pdf, July 25, 2006.
23. Keely JL, American College of Physicians - American Society of Internal Medicine. Pharmacist scope of practice. Ann Intern Med. 2002;136:79-85.
24. Florida statutes. Regulation of professions and occupations: pharmacy, 465.186.
25. U.S. Food and Drug Administration. Center for Drug Evaluation and Research. Plan B (0.75 mg levonorgestrel) tablets information. Accessed at www.fda.gov/cder/drug/infopage/planB/default.htm, November 10, 2006.
26. Cohen JP, Paquette C, Cairns CP. Switching prescription drugs to over the counter. BMJ. 2005;330:39-41.
27. Strom BL. Statins and over-the-counter availability. N Engl J Med. 2005;352:1403-5.
28. Gotto AM Jr. Over-the-counter statins are worth considering in primary prevention of cardiovascular disease. Circulation. 2006;114:1310-4. Accessed at http://circ.ahajournals.org/cgi/content/full/114/12/1310, March 22, 2007.
29. New Mexico occupational and professional licensing: pharmacists, pharmacist clinician. Title 16, Chapter 19, Part 4.17.
30. North Carolina administrative code: clinical pharmacist practitioner, NCAC 46.3101.
31. Ried L, Wang F, Young H, Awiphan R. Patients' satisfaction and their perception of the pharmacist. J Am Pharm Assoc. 1999;39:835-42.
32. Assa-Eley M, Kimberlin C. Using interpersonal perception to characterize pharmacists' and patients' perceptions of the benefits of pharmaceutical care. Health Commun. 2005;17:41-56.